Chintu Patel Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Chintu Patel is Co-CEO of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 864,033 shares of AMRX, which is worth approximately $7.54 Million. The most recent transaction as insider was on Mar 04, 2025, when has been sold 46,528 shares (Class A Common Stock) at a price of $8.84 per share, resulting in proceeds of $411,307. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 864K

68.57% 3M change

68.57% 12M change

Total Value Held $7.54 Million

Chintu Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2025	SELL Payment of exercise price or tax liability	$411,307 $8.84 p/Share	46,528 Reduced 5.11%	864,033 Class A Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	92,592 Added 9.23%	910,561 Class A Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$2,402,929 $8.76 p/Share	274,307 Reduced 25.11%	817,969 Class A Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	-	579,710 Added 34.67%	1,092,276 Class A Common Stock
Dec 16 2021	BUY Open market or private purchase	$212,500 $4.25 p/Share	50,000 Added 8.89%	512,566 Class A Common Stock
Dec 15 2021	BUY Open market or private purchase	$413,000 $4.13 p/Share	100,000 Added 17.78%	462,566 Class A Common Stock

Chintu Patel

Co-CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account